Following a comprehensive strategic review of its Moulded Glass business, Gerresheimer has decided to separate the business and intends to subsequently initiate a sales process for the business unit. The aim of the strategic review was to evaluate various options for the best growth prospects and competitiveness of the Moulded Glass business. The company now sees these outside the Gerresheimer Group.
“We see the best growth opportunities for our newly formed Moulded Glass Powerhouse outside the Gerresheimer Group,” said Dietmar Siemssen, CEO of Gerresheimer. “As part of our strategic transformation, Gerresheimer will focus even stronger on the portfolio of systems and solutions for the pharma and biotech industry.”
Global “Moulded Glass Powerhouse”
The combined Moulded Glass business of Gerresheimer and Bormioli Pharma comprises eight production plants in Germany, Belgium, Italy, the United States and India. With around 3,700 employees, the business unit generated pro forma revenues of around EUR 735 million and an adjusted EBITDA margin of around 20 percent in the financial year 2024. The Moulded Glass Powerhouse provides extensive expertise and global production capabilities for type I, II and III glass products, including decoration and customisation. The diversified portfolio includes all kinds of glass packaging for the pharma, cosmetics and food and beverage industries, such as bottles, containers, jars and flacons.
Gerresheimer continuously invests in state-of-the-art technology for its glass production in all of the Moulded Glass plants. For example, the company has invested around EUR 100 million in an expansion and modernisation project at its Moulded Glass site in Lohr am Main, Germany, over the past two years, installing a state-of-the-art, energy-efficient oxy-hybrid furnace.
Start of the separation of Moulded Glass
As part of the integration of Bormioli Pharma into the Gerresheimer Group, Gerresheimer has begun to establish the combined Moulded Glass business as a global, stand-alone powerhouse. This decision marks the beginning of the separation process. Subsequently the company intends to initiate a sales process. Gerresheimer will provide a further update at its upcoming Capital Markets Day on October 15, 2025.